Literature DB >> 17458891

WWOX in biological control and tumorigenesis.

Rami I Aqeilan1, Carlo M Croce.   

Abstract

The WW domain-containing oxidoreductase (WWOX) gene is located at 16q23.1-16q23.2, a region that spans the second most common human fragile site, FRA16D. The WWOX protein contains two N-terminal WW domains and a central short chain oxidoreductase-like domain. In the last few years, considerable amount of data have shown inactivation of WWOX in a variety of human malignancies. Moreover, interacting partners have been identified biochemically that define, at least in part, the molecular mechanism of WWOX action. Recently, we demonstrated that targeted deletion of the Wwox gene in the mouse led to increased incidence of spontaneous and chemically induced tumor formation, thereby providing the first in vivo evidence that WWOX is a bona fide tumor suppressor. This review focuses on the most recent progress in understanding WWOX function as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458891     DOI: 10.1002/jcp.21099

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  75 in total

1.  Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.

Authors:  Kyle C Kurek; Sara Del Mare; Zaidoun Salah; Suhaib Abdeen; Hussain Sadiq; Suk-Hee Lee; Eugenio Gaudio; Nicola Zanesi; Kevin B Jones; Barry DeYoung; Gail Amir; Mark Gebhardt; Matthew Warman; Gary S Stein; Janet L Stein; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors.

Authors:  Jenny Karlsson; Linda Holmquist Mengelbier; Peter Elfving; David Gisselsson Nord
Journal:  Virchows Arch       Date:  2011-09-23       Impact factor: 4.064

Review 3.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 4.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

5.  Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

Authors:  Ethan M Lange; Jennifer L Beebe-Dimmer; Anna M Ray; Kimberly A Zuhlke; Jaclyn Ellis; Yunfei Wang; Sarah Walters; Kathleen A Cooney
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

6.  WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.

Authors:  Dong Wei; Xiaowen Zhang; Hao Zou; Lin Wang; Bimang Fu; Xuesong Wu; Zhiling Luo; Xiao Li; Jiayun Ge; Yuehua Li; Hong Zhu; Kun Wang; Tao Wang; Pei Yang; Zongliu Hou; Wenju Wang
Journal:  Tumour Biol       Date:  2013-10-15

7.  Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.

Authors:  Rami I Aqeilan; John P Hagan; Haifa A Aqeilan; Flavia Pichiorri; Louise Y Y Fong; Carlo M Croce
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

8.  Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.

Authors:  Suhaib K Abdeen; Sara Del Mare; Sadeeq Hussain; Muhannad Abu-Remaileh; Zaidoun Salah; John Hagan; Maysoon Rawahneh; Xin-An Pu; Stacey Russell; Janet L Stein; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

9.  Genome wide DNA-profiling of HIV-related B-cell lymphomas.

Authors:  Daniela Capello; Marta Scandurra; Giulia Poretti; Paola M V Rancoita; Michael Mian; Annunziata Gloghini; Clara Deambrogi; Maurizio Martini; Davide Rossi; Timothy C Greiner; Wing C Chan; Maurilio Ponzoni; Santiago M Moreno; Miguel A Piris; Vincenzo Canzonieri; Michele Spina; Umberto Tirelli; Giorgio Inghirami; Andrea Rinaldi; Emanuele Zucca; Riccardo D Favera; Franco Cavalli; Luigi Maria Larocca; Ivo Kwee; Antonino Carbone; Gianluca Gaidano; Francesco Bertoni
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

10.  WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.

Authors:  Jenny C Lee; Daphna Weissglas-Volkov; Mira Kyttälä; Zari Dastani; Rita M Cantor; Eric M Sobel; Christopher L Plaisier; James C Engert; Marleen M J van Greevenbroek; John P Kane; Mary J Malloy; Clive R Pullinger; Adriana Huertas-Vazquez; Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Tjerk W A de Bruin; Bradley E Aouizerat; Carla C J van der Kallen; Carlo M Croce; Rami I Aqeilan; Michel Marcil; Jorma S A Viikari; Terho Lehtimäki; Olli T Raitakari; Johanna Kuusisto; Markku Laakso; Marja-Riitta Taskinen; Jacques Genest; Päivi Pajukanta
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.